Skip to main content

Dihydropyrimidinase Deficiency: The First Feline Case of Dihydropyrimidinuria with Clinical and Molecular Findings

  • Research Report
  • Chapter
  • First Online:
JIMD Reports - Case and Research Reports, 2012/3

Abstract

Dihydropyrimidinase (DHP, EC 3.5.2.2) is the second enzyme of the pyrimidine degradation pathway and a deficiency of this enzyme is responsible for a rare inborn metabolic syndrome characterized by dihydropyrimidinuria. Here we report a cat with DHP deficiency, manifesting malnutrition, depression, vomiting, and hyperammonemia. A gas chromatographic–mass spectrometric analysis of urinary metabolic substances showed the presence of large amounts of dihydrouracil and dihydrothymine and moderate amounts of uracil and thymine, suggesting DHP deficiency. Analysis of the feline DPYS gene encoding DHP demonstrated that the cat was homozygous for the missense mutation c.1303G>A (p.G435R) in exon 8, which corresponds to a known mutation in a human patient with DHP deficiency. Population screening in 1,000 cats did not reveal any animal possessing this mutation, suggesting the prevalence of the mutant allele to be very low. This is the first report of naturally occurring DHP deficiency in animals and the cat represents a model of the human disease.

Competing interests: None declared

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 84.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 109.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  • Assmann B, Hoffmann GF, Wagner L et al (1997) Dihydropyrimidinase deficiency and congenital microvillous atrophy: coincidence or genetic relation? J Inherit Metab Dis 20:681–688

    Article  PubMed  CAS  Google Scholar 

  • Chang HS, Arai T, Yabuki A et al (2010) Rapid and reliable genotyping technique for GM1 gangliosidosis in Shiba dogs by real-time polymerase chain reaction with TaqMan minor groove binder probes. J Vet Diagn Invest 22:234–237

    Article  PubMed  Google Scholar 

  • Duran M, Rovers P, de Bree PK et al (1990) Dihydropyrimidinuria. Lancet 336:817–818

    Article  PubMed  CAS  Google Scholar 

  • Duran M, Rovers P, de Bree PK et al (1991) Dihydropyrimidinuria: a new inborn error of pyrimidine metabolism. J Inherit Metab Dis 14:367–370

    Article  PubMed  CAS  Google Scholar 

  • Hamajima N, Kouwaki M, Vreken P et al (1998) Dihydropyrimidinase deficiency: structural organization, chromosomal localization, and mutation analysis of the human dihydropyrimidinase gene. Am J Hum Genet 63:717–726

    Article  PubMed  CAS  Google Scholar 

  • Harvey HJ, MacEwen EG, Hayes AA (1977) Neurotoxicosis associated with use of 5-fluorouracil in five dogs and one cat. J Am Vet Med Assoc 171:277–278

    PubMed  CAS  Google Scholar 

  • Henderson MJ, Ward K, Simmonds HA, Duley JA, Davies PM (1993) Dihydropyrimidinase deficiency presenting in infancy with severe developmental delay. J Inherit Metab Dis 16:574–576

    Article  PubMed  CAS  Google Scholar 

  • Jurecka A (2009) Inborn errors of purine and pyrimidine metabolism. J Inherit Metab Dis 32:247–263

    Article  PubMed  CAS  Google Scholar 

  • Ohba S, Kidouchi K, Sumi S et al (1994) Dihydropyrimidinuria: the first case in Japan. Adv Exp Med Biol 370:383–386

    PubMed  CAS  Google Scholar 

  • Okeda R, Shibutani M, Matsuo T, Kuroiwa T (1988) Subacute neurotoxicity of 5-fluorouracil and its derivative, carmofur, in cats. Acta Pathol Jpn 38:1255–1266

    PubMed  CAS  Google Scholar 

  • Putman CW, Rotteveel JJ, Wevers RA, van Gennip AH, Bakkeren JA, de Abreu RA (1997) Dihydropyrimidinase deficiency, a progressive neurological disorder? Neuropediatrics 28:106–110

    Article  PubMed  CAS  Google Scholar 

  • Song YZ, Li BX, Hao H, Xin RL, Zhang T, Zhang CH, Kobayashi K, Wang ZN, Zheng XY (2008) Selective screening for inborn errors of metabolism and secondary methylmalonic aciduria in pregnancy at high risk district of neural tube defects: a human metabolome study by GC-MS in China. Clin Biochem 41:616–620

    Article  PubMed  CAS  Google Scholar 

  • Sumi S, Kidouchi K, Hayashi K, Ohba S, Wada Y (1996) Dihydropyrimidinuria without clinical symptoms. J Inherit Metab Dis 19:701–702

    Article  PubMed  CAS  Google Scholar 

  • Sumi S, Imaeda M, Kidouchi K et al (1998) Population and family studies of dihydropyrimidinuria: prevalence, inheritance mode, and risk of fluorouracil toxicity. Am J Med Genet 78:336–340

    Article  PubMed  CAS  Google Scholar 

  • Van Gennip AH, de Abreu RA, van Lenthe H et al (1997) Dihydropyrimidinase deficiency: confirmation of the enzyme defect in dihydropyrimidinuria. J Inherit Metab Dis 20:339–342

    Article  PubMed  Google Scholar 

  • Van Kuilenburg AB, Meinsma R, Zonnenberg BA et al (2003) Dihydropyrimidinase deficiency and severe 5-fluorouracil toxicity. Clin Cancer Res 9:4363–4367

    PubMed  Google Scholar 

  • Van Kuilenburg AB, Meijer J, Dobritzsch D et al (2007) Clinical, biochemical and genetic findings in two siblings with a dihydropyrimidinase deficiency. Mol Genet Metab 91:157–164

    Article  PubMed  Google Scholar 

  • Van Kuilenburg AB, Dobritzsch D, Meijer J et al (2010) Dihydropyrimidinase deficiency: phenotype, genotype and structural consequences in 17 patients. Biochim Biophys Acta 1802:639–648

    Article  PubMed  Google Scholar 

Download references

Acknowledgments

This study was supported financially by grants (20380173, 20-08112, and 21658109, O.Y.) from the Ministry of Education, Culture, Sports, Science and Technology of Japan.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Osamu Yamato .

Editor information

Editors and Affiliations

Additional information

Communicated by: Marinus Duran

Synopsis

Synopsis

This is the first report of naturally occurring dihydropyrimidinase deficiency in animals and the cat represents a model of the human disease.

Rights and permissions

Reprints and permissions

Copyright information

© 2012 SSIEM and Springer-Verlag Berlin Heidelberg

About this chapter

Cite this chapter

Chang, HS. et al. (2012). Dihydropyrimidinase Deficiency: The First Feline Case of Dihydropyrimidinuria with Clinical and Molecular Findings. In: JIMD Reports - Case and Research Reports, 2012/3. JIMD Reports, vol 6. Springer, Berlin, Heidelberg. https://doi.org/10.1007/8904_2012_139

Download citation

  • DOI: https://doi.org/10.1007/8904_2012_139

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Publisher Name: Springer, Berlin, Heidelberg

  • Print ISBN: 978-3-642-28128-0

  • Online ISBN: 978-3-642-28129-7

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics